Lexeo Therapeutics

Lexeo Therapeutics is a New York City–based, clinical-stage genetic medicine company focused on reshaping heart health. It develops precision genetic therapies that target the underlying genetic and molecular drivers of cardiovascular disease, advancing programs into the clinic to pursue durable, disease‑modifying approaches. Lexeo’s mission is to fundamentally change how cardiovascular conditions are treated by applying pioneering science to deliver new therapeutic options.